Advanced Breast Cancer: Challenges in Pathways Development

What's New and on the Horizon for Metastatic Breast Cancer?Подробнее

Biosimilars and Oncology Clinical Pathways: Perfect TogetherПодробнее

Integrating Novel Developments for Advanced and Metastatic Breast Cancer into Improved Care PathwaysПодробнее

Metastatic Breast Cancer: Leveraging Clinical Pathways to Navigate a Complex Treatment Landscape:Подробнее

The evolution of advanced breast cancer managementПодробнее

Dr. Brufsky on Challenges in Breast CancerПодробнее

Hormone Receptor-Positive Advanced Breast Cancer: Challenges and New Treatment OptionsПодробнее

How is the patient journey for advanced breast cancer patients different?Подробнее

Understanding Breast CancerПодробнее

Improving Survival for Advanced Breast Cancer with Massimo Cristofanilli, MDПодробнее

How does the advanced breast cancer treatment journey differ for patients?Подробнее

NCI Experts Discuss Challenges in Breast Cancer ResearchПодробнее

Thriving and Breast Cancer: What we've learned from the Pathways studyПодробнее

AMEERA-5: amcenestrant + palbociclib for previously untreated ER+/HER2- advanced breast cancerПодробнее

Genetics & Breast Cancer: Learnings From the Pathways Study and Clinical PracticeПодробнее

Breast Cancer Pathway Guidelines for PractitionersПодробнее

2022 West Oncology Conference | Precision Oncology in HR+ Breast CancerПодробнее

Considering CDK4/6 Inhibitors in Advanced Breast CancerПодробнее

Guidelines and management of advanced breast cancer in limited resource settingsПодробнее